| cell line | Q21014462 |
| cancer cell line | Q23058136 |
| P2158 | Cell Line Ontology ID | CLO_0002548 |
| P3289 | Cellosaurus ID | CVCL_0221 |
| P2888 | exact match | http://purl.obolibrary.org/obo/BTO_0003440 |
| http://purl.obolibrary.org/obo/CLO_0002548 | ||
| http://purl.obolibrary.org/obo/EFO_0002710 |
| P9072 | derived from organism type | Homo sapiens | Q15978631 |
| P1343 | described by source | Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. | Q31034362 |
| Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. | Q38488416 | ||
| Non-random chromosomal rearrangements in pancreatic cancer cell lines identified by spectral karyotyping | Q38494511 | ||
| Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling | Q40009124 | ||
| Identifying allelic loss and homozygous deletions in pancreatic cancer without matched normals using high-density single-nucleotide polymorphism arrays | Q40243352 | ||
| A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene | Q40640693 | ||
| Human cell line (COLO 357) of metastatic pancreatic adenocarcinoma | Q42800640 | ||
| Inhibition of growth of human or hamster pancreatic cancer cell lines by alpha-difluoromethylornithine alone and combined with cis-diamminedichloroplatinum(II). | Q42822790 | ||
| A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform | Q44401579 | ||
| Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture | Q52828892 | ||
| Six monoclonal antibodies to human pancreatic cancer antigens. | Q52828910 | ||
| p53 and K-RAS alterations in pancreatic epithelial cell lesions | Q70545075 | ||
| Distribution of Characteristic Mutations in Native Ductal Adenocarcinoma of the Pancreas and Pancreatic Cancer Cell Lines | Q107100960 | ||
| P5166 | established from medical condition | adenosquamous pancreas carcinoma | Q18556917 |
| Q44401579 | A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform |
| Q40640693 | A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene |
| Q40009124 | Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling |
| Q31034362 | Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. |
| Q42800640 | Human cell line (COLO 357) of metastatic pancreatic adenocarcinoma |
| Q42822790 | Inhibition of growth of human or hamster pancreatic cancer cell lines by alpha-difluoromethylornithine alone and combined with cis-diamminedichloroplatinum(II). |
| Q38494511 | Non-random chromosomal rearrangements in pancreatic cancer cell lines identified by spectral karyotyping |
| Q52828892 | Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture |
| Q52828910 | Six monoclonal antibodies to human pancreatic cancer antigens. |
Search more.